Cutera (CUTRQ) Osake Kurssi

Cutera Inc is primarily active in the medical aesthetics industry, specializing in the development and manufacture of laser and other energy-based devices for aesthetic procedures. Their advanced technologies are used in various medical practices, including plastic surgery, dermatology, and cosmetic surgery. Cutera Inc's commitment to innovation and providing effective solutions has made them a leading player in the aesthetic medical device market. With a strong focus on delivering safe and proven results, Cutera Inc has gained prominence as a trusted name in the field of medical aesthetics.

Some of the main competitors of Cutera Inc in the market include Cynosure, Syneron Medical Ltd, and Lumenis Ltd. These companies also specialize in medical aesthetics and offer a range of similar products and services to Cutera Inc. However, Cutera Inc is known for its unique and innovative approach, distinguishing itself from competitors through its advanced technologies and customer-oriented solutions.

Cutera Inc. is a leading provider of energy-based medical aesthetic technologies. Established in 1998, the company has a rich history of innovation and expertise in the field of laser and energy-based devices for dermatology, aesthetics, and other medical specialties. Cutera is renowned for its advanced technologies, including its flagship excel V™ laser system for vascular and pigmented lesions. With a strong commitment to research and development, Cutera continues to introduce groundbreaking solutions that help medical professionals enhance patient outcomes. Headquartered in Brisbane, California, Cutera Inc. operates globally and remains at the forefront of the evolving aesthetics industry.

Cutera Inc has achieved several significant milestones throughout its history. One notable milestone was the development of their groundbreaking laser and energy-based aesthetic systems, which have revolutionized the medical aesthetics industry. Another milestone was the company's successful expansion into international markets, establishing a strong global presence. Cutera Inc also achieved notable clinical advancements, such as the introduction of innovative technologies for skin rejuvenation and hair removal. The company has consistently focused on research and development, resulting in numerous FDA clearances and patents. These achievements have solidified Cutera Inc's position as a leader in the industry, constantly pushing boundaries and delivering innovative solutions to their customers.

Cutera Inc is primarily present in various countries and regions around the world. The company operates in North America, including the United States and Canada, where it has a significant presence. Additionally, Cutera Inc has a strong presence in Europe, including countries like Germany, France, and the United Kingdom. Furthermore, the company has established its market in the Asia-Pacific region, specifically in countries such as Japan, China, and Australia. With its global reach, Cutera Inc caters to a diverse customer base across different continents, making it a prominent player in the international stock market.

Cutera Inc represents a commitment to innovation, results-driven technology, and exceptional patient care. With a strong corporate philosophy focused on helping individuals enhance their self-confidence and well-being, Cutera Inc strives to provide advanced aesthetic solutions. The company's values encompass integrity, collaboration, and customer satisfaction. By utilizing cutting-edge technology and continuously investing in research and development, Cutera Inc aims to deliver safe and effective aesthetic procedures to its global clientele. With a strong emphasis on quality and innovation, Cutera Inc sets itself apart as a leading provider in the aesthetics industry.

11 analyytikkoa arvioi tällä hetkellä Cutera-osaketta: 8 suosittaa ostoa, 3 pitoa ja 0 myyntiä. Vuodelle 2026 analyytikot odottavat Cutera-yhtiöltä 170,63 M USD liikevaihtoa ja −2,69 USD osakekohtaista tulosta.

Cutera Analyytikkojen kursstavoitteet 2026

Nykyisellä valuuttakurssilla Cutera-osake noteerataan hintaan 0,01 EUR (0,01 USD).

Cutera-osake (CUTRQ) on listattuna 3 pörssissä, muun muassa: NASDAQ (CUTR), Frankfurt (TJ9.F), Düsseldorf (TJ9.DU).

Cutera Inc is a leading company in the field of aesthetic laser technologies. The company was founded in 1998 and is headquartered in California, USA. Cutera offers its customers laser and light-based solutions to improve the skin and body. Cutera's business model encompasses various sectors such as medicine and beauty. Cutera focuses on developing products and devices that have a wide range of applications in aesthetic and medical dermatology. Cutera's products include a variety of laser systems that can be used for different applications. The laser systems are used in both medical dermatology and aesthetic dermatology. Cutera's medical devices are highly precise and can reach the deepest layers of the skin. They are used in the treatment of various skin conditions and disorders. The company also offers products that can be used in the cosmetics and wellness industry. One example of Cutera's products is the xeo® laser system. It is a versatile system that has a wide range of applications, including hair removal, wrinkle reduction, acne treatment, pigmentation, vascular lesion removal, and body contouring. The xeo® laser system uses the latest technology to ensure the highest performance and precision in treatment. Another product from Cutera is the Excel V+ laser system. It is a powerful device used in the treatment of vascular lesions and pigmentation. The system is also capable of treating redness and rosacea and can improve skin color and texture. The Excel V+ laser system is able to perform very precise and efficient treatments, making it highly valued in dermatological treatment. Cutera operates a global business and its products are sold worldwide. The company has distribution partnerships in North America, Europe, Asia (including China), and Australia. Cutera's business model is based on selling medical and aesthetic laser systems, as well as selling accessories and medical devices. Cutera's customers are doctors, medical facilities, and beauty studios. Cutera also has strong customer loyalty and offers a wide range of training and support services to ensure that customers can make the most of their products. The company organizes seminars and training sessions to educate customers on product use and facilitate handling any difficulties. Cutera has a highly effective business model based on the development of innovative products. The company has a strong presence in the market for aesthetic laser technologies and medical devices, and its products are used worldwide. The business model is based on a strong distribution network and excellent customer support. Cutera will continue to invest in the development of innovative products and expand its presence in the global market in the future.

odotettu liikevaihto Cutera on 170,63 M USD. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.

odotettu voitto Cutera on −53,44 M USD. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.

Cutera:n hinta-voitto-suhde (P/E) on tällä hetkellä −0,00. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Cutera-osakkeen arvostusta.

Cutera:n hinta-myynti-suhde (P/S) on tällä hetkellä 0,00. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Cutera-osakkeen arvostuskennuslukuna.

Cutera:n Eulpool-laatuscore on 6/10.

Cutera:n ISIN on US2321091082. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.

Cutera:n WKN on A0B9QG. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.

Cutera:n ticker on CUTRQ. Tämä pörssinoteeraus käytetään Cutera-osakkeiden kauppaan pörssissä.